OrbiMed, Novo A/S invest in $33 mln growth funding in SI-BONE

SI-BONE, a medical device company, has closed a $33 million growth capital financing round. Orbimed and Novo A/S invested in the funding round, along with existing investors Skyline Ventures and Montreux Equity Partners.

North AmericaUSBriefs